Sangamo Therapeutics Inc (SGMO) — Free Cash Flow Generation Index
Sangamo Therapeutics Inc (SGMO) has a Free Cash Flow Generation Index of 0.99x as of September 2024. Free cash flow of $11.64 Million represents 1% of operating cash flow ($11.76 Million). See SGMO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Free Cash Flow Generation Index (2017–2020)
Historical FCF Generation Index trend for Sangamo Therapeutics Inc across 3 annual periods. Explore Sangamo Therapeutics Inc (SGMO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sangamo Therapeutics Inc (2017–2020)
Year-by-year Free Cash Flow Generation Index for Sangamo Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Sangamo Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.91x | $155.16 Million | $169.88 Million | $14.71 Million | ▲ +673.9% |
| 2018 | -0.16x | $-5.91 Million | $37.15 Million | $43.06 Million | ▼ -124.0% |
| 2017 | 0.66x | $7.43 Million | $11.18 Million | $3.75 Million | — |